Efficacy Evaluation of Avance QQ Collagen for Skin Beautification
NCT ID: NCT06771388
Last Updated: 2025-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2024-11-01
2025-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Testing of Collagen Drink on Skin Beauty and Sleep Aid
NCT05182814
Evaluation of the Skin-Beautifying Effects of Collagen Drinks
NCT06900660
Efficacy Testing of Collagen Elixir
NCT04878536
Hydrolyzed Collagen Combined With Djulis and Green Caviar Improve Skin Condition
NCT04709588
Efficacy Evaluation of Collagen Drink Products
NCT06194487
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo drink
Placebo drink
consume 50 g liquid drink daily for 8 consecutive weeks
Non-liposomal collagen drink
Non-liposomal collagen drink
consume 50 g liquid drink daily for 8 consecutive weeks
Liposomal collagen drink
Liposomal collagen drink
consume 50 g liquid drink daily for 8 consecutive weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Liposomal collagen drink
consume 50 g liquid drink daily for 8 consecutive weeks
Non-liposomal collagen drink
consume 50 g liquid drink daily for 8 consecutive weeks
Placebo drink
consume 50 g liquid drink daily for 8 consecutive weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The grade of crow's feet above 2 (Han et al. Sci Rep 13, 18903 (2023));
* Commitment not to use products having activity comparable with that of the product to be tested during the study period;
* Free of any dermatological or systemic disorder that would interfere with results.
Exclusion Criteria
* Subject who had oral or topical medication which may affect skin condition within 1 month;
* Subject who is a vegetarian or likely to be acutely allergic to the listed ingredients in the product;
* Female who is pregnant, nursing or planning to become pregnant during the course of the study;
* Received facial laser therapy, chemical peeling in the past 2 months.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TCI Co., Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chia-Hua Liang, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Chia Nan University of Pharmacy ＆ Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chia Nan University of Pharmacy & Science
Pingtung City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-088-B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.